Navigation Links
BMC to protect its rights in patent fight with ResMed
Date:12/12/2013

BEIJING, Dec. 12, 2013 /PRNewswire/ -- BMC Medical Co., Ltd (BMC) is a specialist of sleep diagnosis and therapy and headquartered in China. On 11 November 2013, right before the commencement of the MEDICA trade show in Düsseldorf, Germany, ResMed filed applications for preliminary injunctions against BMC with the District Court Munich I, Germany, prohibiting BMC from selling or marketing certain products in Germany including BMC's RESmart CPAP devices and BMC's Willow/FeaLite nasal pillows.

(Logo: http://www.prnasia.com/sa/2013/12/05/20131205202544523773.jpg

Dr. Ulrich Worm, head of IP Germany and Partner of global law firm Mayer Brown, retained by BMC to represent BMC in the patent fight, points out: "The preliminary injunctions are issued as a result of ex parte proceedings, which means that the court did not hear, and could not take into account of, BMC's side of the story. Until now, no court hearing has been conducted."

James Xu, General Manager of BMC, states: "We will take all the measures required to defend our IP and products, thus protecting our consumer and business interests against the preliminary injunctions."

In the same vein, in July of this year, ResMed initiated two legal proceedings in the U.S. at the ITC and the Federal District Court of Southern California, alleging that BMC infringed its patents. BMC has retained a noted ITC 337 and patent specialist, Gary Hnath of Mayer Brown to fully contest the proceedings. Gary Hnath has indicated that he is confident that BMC will be able to demonstrate that each patent asserted by ResMed in the U.S. is either not infringed, invalid, or both.

About BMC

BMC Medical Co., Ltd is a specialist of sleep diagnosis and therapy, with continuous product research and development, constant innovation, aiming at providing best respiratory homecare and service. For more information on BMC, visit http://en.bmc-medical.com.


'/>"/>
SOURCE BMC Medical Co., Ltd.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Inovio Pharmaceuticals Granted U.S. Patent Protection for Synthetic Vaccine for Cervical Dysplasia and Cancer
2. Biomedical Advanced Research and Development Authority (BARDA) Exercises Option with Pfenex Inc. To Extend Contract for the Development of a Recombinant Protective Antigen (rPA) Based Anthrax Vaccine
3. Broad Patent Protection Granted for iBio Immunomodulator
4. Life Extension Foundation® study finds Cognitex® with NeuroProtection Complex may provide a positive impact on cognitive performance
5. Inovio Pharmaceuticals Universal Avian Flu Vaccine Generates Protective Antibody Responses Against Six H5N1 Viruses in Phase I Trial
6. China Botanic Sponsors Wild Plant Protection Association of China Meeting; Expects to Lead the Siberian Ginseng Conservation Association
7. Ivera Medical Announces Patent Award for Curos® Port Protectors
8. Burlington Medical Supplies Offers No Fog Eyewear For X-Ray Protection
9. Protected Classes Prescription Drug Mandates Would Hike Small Business Costs, Drug Company Profits
10. Government Affairs Groups Play Critical Role in Protecting Organizations in Turbulent Times
11. Family Research Council: Newland Family Offered Temporary Protection from Obamas Abortion Drug Mandate
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/11/2017)... 2017 Oramed Pharmaceuticals Inc. (NASDAQ: ... focused on the development of oral drug delivery systems, ... (FDA) has agreed to schedule an End-of-Phase II meeting ... of its oral insulin capsule ORMD-0801 in the treatment ... primary and secondary endpoints by indicating a statistically significant ...
(Date:7/10/2017)... July 10, 2017  The tenth annual BioPharm ... MA at the Sheraton Boston Hotel, September ... access to global decision makers and innovative biotech startup ... science leaders during two impactful days. BioPharm America is ... with additional networking opportunities with 4,500+ life science industry ...
(Date:7/5/2017)... Oramed Pharmaceuticals Inc. (NASDAQ: ... clinical-stage pharmaceutical company focused on the development of oral drug ... the Israel Securities Authority to dual-list its common stock on ... commence trading on the TASE on July 12, 2017 under ... the Company, it is expected that Oramed will be included ...
Breaking Medicine Technology:
(Date:7/20/2017)... ... July 19, 2017 , ... A July 5th ... weight loss surgery patients who had received a body contouring procedure reported experiencing a ... clinic Beverly Hills Physicians (BHP), which provides both types of procedures, notes that this ...
(Date:7/20/2017)... ... July 20, 2017 , ... “Fidget”: a fun-filled, action-packed ... retired public high school music and drama teacher who was a summa cum laude ... including a “Teacher of the Year” award. After her retirement from public school, Lynn ...
(Date:7/18/2017)... Oaks, CA (PRWEB) , ... July 18, 2017 , ... ... Ph.D. scientist extracted cannabis oils, announced today that at the WORLDZ Summit, taking place ... will be speaking on the therapeutic benefits of medical cannabis for both pediatric and ...
(Date:7/18/2017)... ... July 18, 2017 , ... ClinicalTrials.gov ... Decisions Do You Need to Consider?, **An FDAnews Webinar**, Aug. 2, 2017 — ... Part 11, “Final Rule for Clinical Trials Registration and Results Information,” is a ...
(Date:7/18/2017)... (PRWEB) , ... July 18, 2017 , ... ... on a lien basis, partners with the best medical professionals who offer the ... and pre-approves each medical professional in their network, ensuring that each patient receives ...
Breaking Medicine News(10 mins):